Loading…
Concurrent hyperadrenocorticism and diabetes mellitus in dogs
Hyperadrenocorticism (HAC) and diabetes mellitus (DM) are two diseases that can occur concurrently in dogs. The objective of this study was to evaluate the coexistence of HAC and DM, and the risk factors involved that could contribute to the development of DM in dogs with HAC. A total of 235 dogs wi...
Saved in:
Published in: | Research in veterinary science 2017-12, Vol.115, p.425-431 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Hyperadrenocorticism (HAC) and diabetes mellitus (DM) are two diseases that can occur concurrently in dogs. The objective of this study was to evaluate the coexistence of HAC and DM, and the risk factors involved that could contribute to the development of DM in dogs with HAC. A total of 235 dogs with HAC were studied and, according to their fasting glycemia, they were divided into three groups: 10.08mmol/L. The following parameters were evaluated: age, gender, cause of HAC, body condition, glycemia, total cholesterol, triglycerides, urinary cortisol:creatinin ratio (UCCR) and survival time. A 13.61% concurrence of HAC and DM was observed. Dogs with a fasting glycemia >5.6mmol/L, with dislipemia, with Pituitary-Dependent Hyperadrenocorticism, UCCR >100×10−6 and non-castrated females showed a higher risk of developing DM. The development of DM in dogs with HAC reduces the survival time.
•Diabetes mellitus and hyperadrenocorticism in dogs are frequently associated.•Glycemia >5.6mmol/L increase the risk to develop diabetes mellitus.•UCCR >100×10−6 are associated with the high risk to develop diabetes mellitus.•Life expectancy are reduced in case of diabetes mellitus and hyperadrenocorticism. |
---|---|
ISSN: | 0034-5288 1532-2661 |
DOI: | 10.1016/j.rvsc.2017.07.026 |